insiders

Twenty-two minutes after regular market hours closed on July 2, an Orbimed Advisors Form 4 relating to Corvus Pharmaceuticals Inc (CRVS) was posted on the SEC's website. The hedge fund, a 10%+ holder and insider in CRVS, disclosed that between June 27 and July 1 it...

Cigna Insider Buying is a rarity. Only one corporate insider had bought shares of the giant health insurer on the open market since 2003. That changed dramatically on Monday, as Cigna (CI) CEO David Cordani disclosed the purchase of 32,509 shares of his company's stock at $155.17....

On Dec. 23, Nierenberg Investment filed a 13D/A on Houston Wire and Cable (HWCC). The investment adviser expressed frustration that the market value of its long-held position in the micro-cap has "widened substantially over the last two years." The filing amended a 13D...

If you’re an officer or director of a public company, this is your worst nightmare: You’re sipping coffee at work one morning when a FedEx package is dropped on your desk. Inside you find a letter from the SEC notifying you of a court date to answer charges of trading on inside information. A scenario to be avoided for sure. However, here’s the problem:  The U.S. has no insider trading laws. What? I can hear you saying, then how is it that white collar criminals do time for profiting from secret information? Good question.

In the investing world, those with superior information usually make the most money. And possibly no group has better information on public companies – and profitably acts on it – than corporate insiders at small-cap biotech and medical technology companies.

On Friday, Engaged Capital LLC, a big holder of Hain Celestial Group, announced it bought $19 million more of HAIN, even though the stock had popped 10% over the previous couple days. Often, corporate insiders buy into share weakness...

Solid Biosciences' private placement featured investments by an all star list of top biotech institutional investors. Cambridge-based Solid Biosciences (SLDB) trades at 1/3 of its January 2018 IPO value. But based on the A-list biotech investors buying shares in the company's July 26 $60...

Mauricio Leyva, appointed in March to the newly-created role of President, International and Business Development at Keurig Dr. Pepper (KDP) made a big buy of KDP on Monday. In a Form 4 filed yesterday, Leyva disclosed the purchase of 123,400 KDP at $28.47. The $3.58M buy...

Last week, three insiders from Maiden Holdings, Ltd. (MHLD) filed Form 4s disclosing the purchase of 380,000 shares at an average price of $0.78 per share. An interesting cluster of buying. But here's what's astonishing -- just seven months earlier the stock traded at $8.75.

ConAgra insider Craig Omtvedt bought $1.35 million of the food giants's stock two weeks after ConAgra Brands Inc (CAG) reported surprisingly good earnings and upped its guidance. CAG hit 52-week highs after the report. Omtvedt's Form 4 disclosing his purchase came after market hours on Jan. 3....